Cold Spring Harbor Laboratory Professor Adrian Krainer has been awarded the Jacob and Louise Gabbay Award in Biotechnology and Medicine for his role in the development of a therapy for the neuromuscular disease spinal muscular atrophy (SMA). Krainer shares the prize with C. Frank Bennett from Ionis Pharmaceuticals, with whom he collaborated to develop the first FDA-approved treatment for SMA, a drug called nusinersen (Spinraza®).
The Jacob and Louise Gabbay Award in Biotechnology and Medicine recognizes scientists in academia, medicine, or industry whose work had outstanding scientific content and significant practical consequences in the biomedical sciences. The award, given annually, consists of a medallion and a $25,000 individual cash prize or $30,000 to be shared between multiple winners.
Written by: Sara Roncero-Menendez, Media Strategist | publicaffairs@cshl.edu | 516-367-8455